DCM
TMO icon

Deuterium Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Deuterium Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-782
Closed -$431K – 105
2022
Q4 		$431K Buy
+782
New +$414K 1.14% 23
2022
Q3 		– Sell
-632
Closed -$343K – 58
2022
Q2 		$343K Hold
632
– – 1.16% 21
2022
Q1 		$373K Buy
+632
New +$363K 0.48% 35

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Deuterium Capital Management's TMO Position: Q1 2023 in Review

Deuterium Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 782 shares — an estimated $431K sold.

Deuterium Capital Management first reported a position in TMO in Q1 2022 and held it in 3 quarters. The position peaked at $431K in Q4 2022. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Deuterium Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 782 Thermo Fisher Scientific shares in Q1 2023, an estimated $431K.
  • Deuterium Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 3 quarters.
  • Deuterium Capital Management's Thermo Fisher Scientific position peaked at $431K in Q4 2022.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.